Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Previous Next
Contents: Volume 19, Number 2, February 2008   [Index by Author] 

Down in this issue
Down editorials
Down reviews
Down original articles
     hematologic malignancies
     urogenital tumors
     breast cancer
     gynecologic tumors
     gastrointestinal tumors
     lung cancer
     phase I and pharmacokinetics
     epidemiology
     sarcomas and melanoma
Down letters to the editor


[Search ALL Issues]


Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

in this issue Back

in this issue
Ann Oncol 2008 19: 199; doi:10.1093/annonc/mdm605 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials Back

P. J. Bierman, M. L. Villanueva, and J. O. Armitage
Diffuse large B-cell lymphoma of the breast: a distinct entity?
Annals of Oncology Advance Access published on January 10, 2008
Ann Oncol 2008 19: 201-202; doi:10.1093/annonc/mdm587 [Extract] [Full Text] [PDF] [Request Permissions]  

R. A. Huddart
The management of non-seminomatous germ-cell tumours patients with viable malignancy at the time of RPLND
Ann Oncol 2008 19: 203-204; doi:10.1093/annonc/mdm603 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews Back

W. C. Cho
A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research
Annals of Oncology Advance Access published on August 20, 2007
Ann Oncol 2008 19: 205-211; doi:10.1093/annonc/mdm335 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

M. Findlay, G. von Minckwitz, and A. Wardley
Effective oral chemotherapy for breast cancer: pillars of strength
Annals of Oncology Advance Access published on November 15, 2007
Ann Oncol 2008 19: 212-222; doi:10.1093/annonc/mdm285 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

E. Azambuja, V. Durbecq, D. D. Rosa, M. Colozza, D. Larsimont, M. Piccart-Gebhart, and F. Cardoso
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
Annals of Oncology Advance Access published on September 14, 2007
Ann Oncol 2008 19: 223-232; doi:10.1093/annonc/mdm352 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles Back

hematologic malignancies Back

G. Ryan, G. Martinelli, M. Kuper-Hommel, R. Tsang, G. Pruneri, K. Yuen, D. Roos, A. Lennard, L. Devizzi, S. Crabb, D. Hossfeld, G. Pratt, M. Dell'Olio, S. P. Choo, R. G. Bociek, J. Radford, S. Lade, A. M. Gianni, E. Zucca, F. Cavalli, and J. F. Seymour
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
Annals of Oncology Advance Access published on October 11, 2007
Ann Oncol 2008 19: 233-241; doi:10.1093/annonc/mdm471 [Abstract] [Full Text] [PDF] [Request Permissions]  

E.-K. Song, S.-Y. Kim, T. M. Kim, K.-W. Lee, T. Yun, I.-I. Na, H. Shin, S. H. Lee, D. W. Kim, S. I. Khwarg, and D. S. Heo
Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma
Annals of Oncology Advance Access published on October 17, 2007
Ann Oncol 2008 19: 242-246; doi:10.1093/annonc/mdm457 [Abstract] [Full Text] [PDF] [Request Permissions]  

F. Morschhauser, J. F. Seymour, H. C. Kluin-Nelemans, A. Grigg, M. Wolf, M. Pfreundschuh, H. Tilly, J. Raemaekers, M. B. van 't Veer, N. Milpied, G. Cartron, A. Pezzutto, A. Spencer, F. Reyes, and M. Dreyling
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
Annals of Oncology Advance Access published on September 28, 2007
Ann Oncol 2008 19: 247-253; doi:10.1093/annonc/mdm463 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. S. Portlock, P. Hamlin, A. Noy, W. Chey, C. A. Gaydos, L. Palomba, I. Schwartz, S. Corcoran, L. Rosenzweig, D. Walker, G. Papanicolaou, and A. Markowitz
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy
Annals of Oncology Advance Access published on October 26, 2007
Ann Oncol 2008 19: 254-258; doi:10.1093/annonc/mdm484 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors Back

K. Fizazi, J. Oldenburg, A. Dunant, I. Chen, R. Salvioni, J. T. Hartmann, M. De Santis, G. Daugaard, A. Flechon, U. de Giorgi, S. Tjulandin, H. J. Schmoll, J. Bouzy, S. D. Fossa, and G. Fromont
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study
Annals of Oncology Advance Access published on November 27, 2007
Ann Oncol 2008 19: 259-264; doi:10.1093/annonc/mdm472 [Abstract] [Full Text] [PDF] [Request Permissions]  

I. Tamaskar, R. Bukowski, P. Elson, A. G. Ioachimescu, L. Wood, R. Dreicer, T. Mekhail, J. Garcia, and B. I. Rini
Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 265-268; doi:10.1093/annonc/mdm483 [Abstract] [Full Text] [PDF] [Request Permissions]  

J. Domingo-Domenech, P. L. Fernandez, X. Filella, A. Martinez-Fernandez, R. Molina, E. Fernandez, A. Alcaraz, J. Codony, P. Gascon, and B. Mellado
Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel
Annals of Oncology Advance Access published on November 12, 2007
Ann Oncol 2008 19: 269-275; doi:10.1093/annonc/mdm490 [Abstract] [Full Text] [PDF] [Request Permissions]  

breast cancer Back

T. S. Dabakuyo, F. Bonnetain, P. Roignot, M.-L. Poillot, G. Chaplain, T. Altwegg, G. Hedelin, and P. Arveux
Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 276-283; doi:10.1093/annonc/mdm491 [Abstract] [Full Text] [PDF] [Request Permissions]  

E. Morris, R. A. Haward, M. S. Gilthorpe, C. Craigs, and D. Forman
The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's breast cancer patients
Annals of Oncology Advance Access published on September 4, 2007
Ann Oncol 2008 19: 284-291; doi:10.1093/annonc/mdm432 [Abstract] [Full Text] [PDF] [Request Permissions]  

G. von Minckwitz, S. Kümmel, A. du Bois, W. Eiermann, H. Eidtmann, B. Gerber, J. Hilfrich, J. Huober, S. D. Costa, C. Jackisch, S.-T. Grasshoff, S. Vescia, T. Skacel, S. Loibl, K. M. Mehta, M. Kaufmann, and On behalf of the German Breast Group
Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
Annals of Oncology Advance Access published on September 9, 2007
Ann Oncol 2008 19: 292-298; doi:10.1093/annonc/mdm438 [Abstract] [Full Text] [PDF] [Request Permissions]  

L. Del Mastro, B. Dozin, E. Aitini, T. Catzeddu, E. Baldini, A. Contu, A. Durando, S. Danese, G. Cavazzini, G. Canavese, P. Bruzzi, P. Pronzato, M. Venturini, and and other participants of the GONO-MIG group (Appendix)
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) Group
Annals of Oncology Advance Access published on October 17, 2007
Ann Oncol 2008 19: 299-307; doi:10.1093/annonc/mdm475 [Abstract] [Full Text] [PDF] [Request Permissions]  

E.-L. Alarmo, T. Korhonen, T. Kuukasjärvi, H. Huhtala, K. Holli, and A. Kallioniemi
Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas
Annals of Oncology Advance Access published on September 24, 2007
Ann Oncol 2008 19: 308-314; doi:10.1093/annonc/mdm453 [Abstract] [Full Text] [PDF] [Request Permissions]  

F. Andre, R. Nahta, R. Conforti, T. Boulet, M. Aziz, L. X. H. Yuan, F. Meslin, M. Spielmann, G. Tomasic, L. Pusztai, G. N. Hortobagyi, S. Michiels, S. Delaloge, and F. J. Esteva
Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer
Annals of Oncology Advance Access published on September 5, 2007
Ann Oncol 2008 19: 315-320; doi:10.1093/annonc/mdm429 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors Back

J.-M. Lee, K.-B. Lee, J.-H. Nam, S.-Y. Ryu, D.-S. Bae, J.-T. Park, S.-C. Kim, S.-D. Cha, K.-R. Kim, S.-Y. Song, and S.-B. Kang
Prognostic factors in FIGO stage IB–IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 321-326; doi:10.1093/annonc/mdm465 [Abstract] [Full Text] [PDF] [Request Permissions]  

A. Prat, M. Parera, S. Peralta, M. A. Perez-Benavente, A. Garcia, A. Gil-Moreno, J. M. Martinez-Palones, I. Roxana, J. Baselga, and J. M. Del Campo
Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer
Annals of Oncology Advance Access published on December 6, 2007
Ann Oncol 2008 19: 327-331; doi:10.1093/annonc/mdm495 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors Back

E. Van Cutsem, C. Verslype, P. Beale, S. Clarke, R. Bugat, A. Rakhit, S. H. Fettner, U. Brennscheidt, A. Feyereislova, and J.-P Delord
A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients
Annals of Oncology Advance Access published on November 6, 2007
Ann Oncol 2008 19: 332-339; doi:10.1093/annonc/mdm452 [Abstract] [Full Text] [PDF] [Request Permissions]  

S. Boeck, T. Hoehler, G. Seipelt, R. Mahlberg, A. Wein, A. Hochhaus, H.-P. Boeck, B. Schmid, E. Kettner, M. Stauch, F. Lordick, Y. Ko, M. Geissler, K. Schoppmeyer, G. Kojouharoff, A. Golf, S. Neugebauer, and V. Heinemann
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 340-347; doi:10.1093/annonc/mdm467 [Abstract] [Full Text] [PDF] [Request Permissions]  

L.F. de Geus-Oei, H. W. M. van Laarhoven, E. P. Visser, R. Hermsen, B. A. van Hoorn, Y. J. L. Kamm, P. F. M. Krabbe, F. H. M. Corstens, C. J. A. Punt, and W. J. G. Oyen
Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 348-352; doi:10.1093/annonc/mdm470 [Abstract] [Full Text] [PDF] [Request Permissions]  

C. Porta, M. De Amici, S. Quaglini, C. Paglino, F. Tagliani, A. Boncimino, R. Moratti, and G. R. Corazza
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 353-358; doi:10.1093/annonc/mdm448 [Abstract] [Full Text] [PDF] [Request Permissions]  

P. J. Perik, B. Rikhof, F. A. de Jong, J. Verweij, J. A. Gietema, and W. T. A. van der Graaf
Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity
Annals of Oncology Advance Access published on October 24, 2007
Ann Oncol 2008 19: 359-361; doi:10.1093/annonc/mdm468 [Abstract] [Full Text] [PDF] [Request Permissions]  

lung cancer Back

R. Rosell, G. Robinet, A. Szczesna, R. Ramlau, M. Constenla, B. C. Mennecier, W. Pfeifer, K. J. O'Byrne, T. Welte, R. Kolb, R. Pirker, A. Chemaissani, M. Perol, M. R. Ranson, P. A. Ellis, K. Pilz, and M. Reck
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on October 17, 2007
Ann Oncol 2008 19: 362-369; doi:10.1093/annonc/mdm474 [Abstract] [Full Text] [PDF] [Request Permissions]  

B. Castagneto, M. Botta, E. Aitini, F. Spigno, D. Degiovanni, O. Alabiso, M. Serra, A. Muzio, R. Carbone, R. Buosi, V. Galbusera, E. Piccolini, L. Giaretto, L. Rebella, and M. Mencoboni
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)
Annals of Oncology Advance Access published on December 20, 2007
Ann Oncol 2008 19: 370-373; doi:10.1093/annonc/mdm501 [Abstract] [Full Text] [PDF] [Request Permissions]  

phase I and pharmacokinetics Back

A. Jimeno, W. A. Messersmith, C. K. Lee, W. W. Ma, D. Laheru, R. C. Donehower, S. D. Baker, and M. Hidalgo
Phase I study of troxacitabine administered by continuous infusion in subjects with advanced solid malignancies
Ann Oncol 2008 19: 374-379; doi:10.1093/annonc/mdm572 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology Back

G. Randi, M. Ferraroni, R. Talamini, W. Garavello, S. Deandrea, A. Decarli, S. Franceschi, and C. La Vecchia
Glycemic index, glycemic load and thyroid cancer risk
Annals of Oncology Advance Access published on October 19, 2007
Ann Oncol 2008 19: 380-383; doi:10.1093/annonc/mdm433 [Abstract] [Full Text] [PDF] [Request Permissions]  

H. Gogas, M. Trakatelli, N. Dessypris, A. Terzidis, A. Katsambas, G. P. Chrousos, and E. T. Petridou
Melanoma risk in association with serum leptin levels and lifestyle parameters: a case–control study
Annals of Oncology Advance Access published on October 8, 2007
Ann Oncol 2008 19: 384-389; doi:10.1093/annonc/mdm464 [Abstract] [Full Text] [PDF] [Request Permissions]  

sarcomas and melanoma Back

R. E. Ferner, J. F. Golding, M. Smith, E. Calonje, W. Jan, V. Sanjayanathan, and M. O'Doherty
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study
Annals of Oncology Advance Access published on October 11, 2007
Ann Oncol 2008 19: 390-394; doi:10.1093/annonc/mdm450 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor Back

P. Mathew
Prolonged control of progressive castration-resistant metastatic prostate cancer with testosterone replacement therapy: the case for a prospective trial
Annals of Oncology Advance Access published on December 20, 2007
Ann Oncol 2008 19: 395-396; doi:10.1093/annonc/mdm568 [Extract] [Full Text] [PDF] [Request Permissions]  

D. Aguiar Bujanda
Complete response of relapsed angioimmunoblastic T-cell lymphoma following therapy with bevacizumab
Ann Oncol 2008 19: 396-397; doi:10.1093/annonc/mdm579 [Extract] [Full Text] [PDF] [Request Permissions]  

E. Yaman, M. Benekli, U. Coskun, B. Ozturk, A. O. Kaya, R. Yildiz, and S. Buyukberber
Reply to the article "Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases" by J.-J. Body et al. (Ann Oncol 2007; 18: 1165–1171)
Ann Oncol 2008 19: 397-398; doi:10.1093/annonc/mdm577 [Extract] [Full Text] [PDF] [Request Permissions]  

J.-J. Body
Reply to Letter to the editor, by E. Yaman et al. (Ann Oncol)
Ann Oncol 2008 19: 398; doi:10.1093/annonc/mdm580 [Extract] [Full Text] [PDF] [Request Permissions]  

S. M. Mousavi, A. A. Alamolhoda, M. M. Gouya, and N. Lickiss
Implementation of Comprehensive National Cancer Control Program in Iran: an experience in a developing country
Ann Oncol 2008 19: 398-400; doi:10.1093/annonc/mdm581 [Extract] [Full Text] [PDF] [Request Permissions]  

Å. Berglund, B. Cedermark, and B. Glimelius
Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?
Ann Oncol 2008 19: 400-402; doi:10.1093/annonc/mdm582 [Extract] [Full Text] [PDF] [Request Permissions]  

M. Di Maio, E. Bria, A. Rossi, and F. Perrone
Progression-free survival as primary end point in advanced non-small-cell lung cancer: does the size matter?
Annals of Oncology Advance Access published on January 6, 2008
Ann Oncol 2008 19: 402-403; doi:10.1093/annonc/mdm586 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.